A third option is suppression: the United States would forgo development of ASI and stop anyone else from building it on the basis that superintelligence is just too dangerous to be unleashed on the ...
Recursion outlines $375M 2026 cash OpEx guidance while advancing first Genentech neuroscience target
We are no longer just discussing the potential of our platform." (CEO, President & Director Najat Khan) "We now have 5 clinical stage programs, including REC-4881 in FAP, where we have generated some ...
On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
JavaScript Explicit Resource Management lands in Safari Technology Preview 250, completing cross-browser support across V8, ...
A macOS ClickFix campaign shifted tactics from openly serving infostealer lures to hiding them behind a browser-fingerprinting gate. The change makes malicious infrastructure harder to detect while ...
The endocrine system is a network of glands and organs that uses chemical messengers called hormones to regulate metabolism, growth, reproduction, heart rate, blood pressure, and sleep-wake cycles.
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results